Oric Pharmaceuticals
ORIC
82 hedge funds and large institutions have $762M invested in Oric Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 34 increasing their positions, 20 reducing their positions, and 6 closing their positions.
70% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 20
67% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 6
19% more capital invested
Capital invested by funds: $639M → $762M (+$123M)
5% more funds holding
Funds holding: 78 → 82 (+4)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
5.86% less ownership
Funds ownership: 98.49% → 92.63% (-5.9%)
Top Buyers
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$12.4M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$10.3M |
| 3 |
EC
Euclidean Capital
New York
|
-$4.45M |
| 4 |
Millennium Management
New York
|
-$4.1M |
| 5 |
State Street
Boston,
Massachusetts
|
-$3.89M |
ORIC Hedge Fund Activity: Q3 2021 in Review
82 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Oric Pharmaceuticals (ORIC) for Q3 2021, worth a combined $762M — up 19% from $639M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new ORIC positions and 6 closed out — a net gain of 4 holders — while 34 added to existing stakes and 20 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $7.97M. The largest seller was Point72 Asset Management, cutting an estimated $12.4M.
- 82 institutional investors held Oric Pharmaceuticals (ORIC) as of Q3 2021, up from 78 in Q2 2021.
- Funds reported $762M of Oric Pharmaceuticals stock for Q3 2021, up 19% quarter-over-quarter.
- 10 funds opened new Oric Pharmaceuticals positions in Q3 2021 and 6 closed out, a net change of +4 holders.
- The largest Oric Pharmaceuticals buyer in Q3 2021 was Fidelity Investments, an estimated $7.97M added.
- The largest Oric Pharmaceuticals seller in Q3 2021 was Point72 Asset Management, an estimated $12.4M sold.
Based on aggregated 13F filings for Q3 2021.